RecruitingPhase 3NCT05668455

Comparison of Topical Treatment for Inflammatory Secretions of the Conjonctiva (Patients With Ocular Prostheses)

Comparison of Topical Hydrocortisone Versus Dexamethasone Treatment for Inflammatory Secretions of the Conjonctiva in Patients With Ocular Prostheses

Sponsor

Agnes

Enrollment

30 participants

Start Date

May 12, 2023

Study Type

INTERVENTIONAL

Conditions

Ocular Inflammation Ocular Prostheses

Summary

We propose to evaluate the efficacy of treatment with Hydrocortisone and Dexamethasone (in a cross-over design) in patients with ocular prostheses and significant functional discomfort.

Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Dexamethasone, a drug called Hydrocortisone, and others for people with ocular inflammation and ocular prostheses. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGHydrocortisone

1 drops 4 times a day

DRUGDexamethasone

1 drops 4 times a day

OTHERPovidone

1 drops 4 times a day

Locations(1)

Centre Hospitalier Universitaire de Rennes _ Pontchaillou

Rennes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05668455

Related Trials

A Study of Ear Nerve Stimulation to Treat Eye Inflammation

NCT07831876

Dextenza in the Post-op Management of Vitreoretinal Surgeries

NCT043714451 location